What makes tesamorelin stand out clinically is that its active peptide was FDA-validated through EGRIFTA SV, the brand-name drug approved specifically for excess visceral fat in HIV patients with lipodystrophy
According to the Mounjaro FDA prescribing information, injection-site reactions redness, itching, swelling, or pain at the injection point occurred in approximately 3-7% of participants across the SURPASS clinical trials depending on dose
BAC water contains benzyl alcohol as a preservative
Monthly consultations with a licensed provider Unlimited support check-ins with the Dr
Dosing, timing, diet, subjective feelings of puffiness, body weight, etc
[2] It should not be used with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI